News & Events

Entry into a Material Definitive Agreement. Stock Purchase Agreement On May 14, 2026, Nexalin Technology, Inc. (the “Company”) entered into a Stock Purchase Agreement (the “Purchase Agreement”) with GreenLight Ventures LLC, a North Carolina limited liability company (“GLV”). Pursuant to the Purchase Agreement, the Company purchased from GLV, 100 shares (the “PONM Shares”) of common stock, no par value, of PONM, Inc., a North Carolina corporation (“PONM”), representing all of the issued and ou…

The Consideration Shares, including the 959,016 shares of Common Stock issued to GLV on the Closing Date, have been or will be issued in reliance on the exemption from registration under the Securities Act of 1933, as amended (the “Securities Act”), provided by Section 4(a)(2) thereof and/or Rule 506(b) of Regulation D promulgated thereunder.

Entry into a Material Definitive Agreement. On April 17, 2026, Nexalin Technology, Inc. (the “Company”) entered into a Scope of Work (the “SOW”) with Lindus Health Limited (“Lindus Health”), a clinical research organization based in the United Kingdom. The SOW is governed by a Master Services Agreement (“MSA”) previously entered into between the parties and sets forth the terms under which Lindus Health will conduct the Company’s pivotal clinical trial for its HALO Clarity device (the “Pivota…

Notice of Delisting of Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. On January 21, 2026, Nexalin Technology, Inc. (the “Company”) received a deficiency letter (the “Notice”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that, based upon the closing bid price of the Company’s common stock, par value $0.001per share (“Common Stock”), for the last 30 consecutive business days, the Company is not current…

Entry into a Material Definitive Agreement. On October 15, 2025, Nexalin Technology, Inc., a Delaware corporation headquartered in Houston, Texas (the “ Company ”), entered into an Amendment No. 2 (the “ Amendment ”) to that certain equity distribution agreement, dated April 29, 2025 (as amended by that certain Amendment No. 1 to the Equity Distribution Agreement, dated May 5, 2025, the “ Equity Distribution Agreement ”) with Maxim Group LLC, as exclusive sales agent (the “ Agent ”). The Equi…

Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. Appointment of Justin Van Fleet as Chief Financial Officer On August 1, 2025, Nexalin Technology, Inc. (the “Company”) announced the appointment of Justin Van Fleet to the position of Chief Financial Officer of the Company. Prior to joining the Company, Mr. Van Fleet served as a partner in the assurance practice of Marcum LLP. With over two decades of experience in public accounting, Mr. Van Fleet has advised publ…

Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. Employment Agreement with Justin Van Fleet On July 17, 2025, Nexalin Technology, Inc. (the “Company”) and Justin Van Fleet entered into an employment agreement (the “Employment Agreement”), pursuant to which Mr. Van Fleet agreed to serve as the Chief Financial Officer of the Company, with the first date of employment to commence on August 1, 2025 (the “Commencement Date”). Prior to joining the Company, Mr. Van Fle…

Other Events. On May 5, 2025, the Company issued a press release announcing the pricing of the Offering. A copy of the press release is attached as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference. Forward-Looking Statements This current report on Form 8-K contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 (“PSLRA”). Such forward-looking statements include but are not limited to statements about…

Entry into a Material Definitive Agreement. On May 4, 2025, Nexalin Technology, Inc. (the “Company”) entered into an underwriting agreement dated as of May 4, 2025 (the “Underwriting Agreement”) with Maxim Group LLC (the “Representative”) in connection with the offering of an aggregate of 3,850,000 shares (“Shares”) of the Company’s common stock (the “Common Stock”), par value $0.001 per share (the “Offering”). The public offering price was $1.30 per Share, before deducting underwriting disco…

Entry into a Material Definitive Agreement. On April 29, 2025, Nexalin Technology, Inc., a Delaware corporation headquartered in Houston, Texas (the “Company”) established an “at-the-market” offering (the “ATM Program”) through which the Company may sell, from time to time through Maxim Group LLC, as exclusive sales agent (the “Agent”), shares of the Company’s common stock, par value $0.001 per share (the “Shares”). On May 5, 2025, in connection with the Company’s effective shelf registration…

Change in Registrant’s Certifying Accountant On November 1, 2024, CBIZ CPAs P.C. acquired the attest business of Marcum LLP (“Marcum”). On April 16, 2025, Marcum informed Nexalin Technology, Inc. (the “Company”) that Marcum resigned as the Company’s independent registered public accounting firm. Also on April 16, 2025, the Company, with the approval of the Audit Committee of the Company’s Board of Directors, engaged CBIZ CPAs P.C. as the Company’s independent registered public accounting firm…